The College of Population Health at Thomas Jefferson University offers a course in Health Data Science, an online program that offers a graduate certificate and a Master’s of Science option. Students may select either a research or a management track, depending on career interests. The course […]
Dascena and BARDA Announce Partnership to Predict Severity of COVID-19 Disease
Data company Dascana will partner with the Biomedical Advanced Research and Development Authority (BARDA). Dascena will use its predictive machine learning algorithm to identify high-risk COVID-19 patients. The tool will allow healthcare providers to streamline their decision-making processes and to […]
Part 2 of Cytel’s Webinar on Considerations for SCAs in Clinical Trials Now Available
A new webinar offered by Cytel details important considerations for researchers seeking to create synthetic control arms (SCAs) using real world data (RWD). Although SCAs are typically considered to be a fast-track method of getting a drug to market, this is an incorrect assumption. SCAs can require […]
One Billion Consumer Records Compromised in CVS Health Database Leak
1 billion CVS Health search records were posted online by mistake in 2021. No authentication was necessary to access these records, which included user email addresses and searches for COVID-19 vaccines. CVS Health has worked to take down the compromised database since becoming aware of the […]
New IQVIA Whitepaper on Analytics-Driven HCP Targeting
IQVIA is offering a whitepaper on improving your organization’s healthcare professional (HCP) targeting. IQVIA offers an analytics tool that incorporates artificial intelligence data to provide a scalable solution. “Precise HCP targeting is critical to maximizing your sales force and marketing […]
Cytel Paper on De-Risking Clinical Trials Using a Data-Driven Method
Cytel has published a position paper on using data to de-risk clinical trials. The paper discusses methods that can be used to determine the pros and cons of several study designs and how to rapidly accelerate an ongoing trial without compromising its power. The whitepaper offers clear strategies to […]
Cytel Data Expert Discusses EHR Integration in Clinical Trials
Associate Director Business Development at Cytel and chair of the eDigital data management expert group Lauren Ellis-Hill discusses her thoughts on the use of electronic health records (EHRs) in clinical trials. She anticipates a continued increase in the use of EHRs in clinical trials, especially […]
Cytel Webinar on Understanding Synthetic Control Arms and Avoiding HTA Rejection
A recent Cytel webinar clarifies common misunderstandings regarding synthetic control arms (SCAs). The use of real world data (RWD) to forgo traditional clinical trials is attractive, but requires a thorough understanding of the purpose of and challenges associated with SCAs. Two common criticisms […]
University of Twente Offers Online Course on Discrete Event Simulation in R
The University of Twente is offering an online course on discrete event simulation (DES) in R. The course will take place in September 2021. Familiarity with R and DES is not required. Register today to secure your spot. “Discrete event simulation is a patient-level simulation modeling method […]
Register today for ISPOR Short Course on Implementing Risk-Sharing Arrangement for Therapeutics and Medical Devices
ISPOR will host a short course on June 29th and 30th from 10:00 AM – 12:00 PM EDT each day. This course will focus on identifying and overcoming challenges related to risk-sharing for pharma and payers. The session will include a case study to highlight opportunities and barriers to a […]
Biogen Partners with Cigna and CVS Health to Promote Access to Contentious Alzheimer’s Drug
Biogen has announced that it will partner with Cigna and CVS Health to improve patient access to aducanumab, which received accelerated FDA approval despite claims that it offers limited clinical benefits. This news comes as payers and other healthcare stakeholders consider a shift to value-based […]
Mississippi Attorney General Sues Both Pharma and PBMs as Insulin Prices Soar
Mississippi has accused insulin manufacturers and pharmacy benefit managers (PBMs) of working together to maintain insulin prices unmanageably high. Mississippi Attorney General Lynn Fitch criticized pharma regarding these policies, noting that vulnerable patient populations are being exploited. […]
White Paper Details Pharmacoeconomics Analysis Considerations
A new white paper, provided by Dr. Nina Lathia, details the critical elements of an effective pharmacoeconomics (PE) analysis. Dr. Lathia draws on her background as a health economist and pharmacist to offer insight into PE analyses. In addition to clear decision-making processes when comparing […]
Former FDA Commissioner Joins Moderna’s Sponsor Flagship Pioneering
Former FDA Commissioner Stephen Hahn has taken a position at venture group Flagship Engineering as CMO of its Preemptive Medicine and Health Security. Flagship Engineering supported Moderna in its COVID-19 vaccine development, a move that has yielded substantial profits once the FDA granted […]
Register Today for Upcoming AMCP Webinar on the Biosimilar Landscape in the United States
The Academy of Managed Care Pharmacy (AMCP) will host a virtual event on biosimilars. The webinar will detail steps than can drive the use of biosimilars in US healthcare and includes points discussed at a multidisciplinary stakeholder meeting in December 2020. The webinar will take place Tuesday, […]
Senate Democrats Discuss Alternative Drug Pricing Bill; Pelosi’s Bill Could Lead to $500 Billion in Savings
Senate Democrats are considering a new proposal to reduce drug prices. New Jersey’s Senator Bob Menendez noted that despite efforts to reduce the financial burden on American consumers, many proposed bills only serve to collect revenue from pharmaceutical companies without passing along these […]
Google Data Used in Vaccine Equity Planner Tool to Identify COVID-19 Vaccine Deserts
Google has released its COVID-19 vaccination data on github, updated weekly to reflect changes in vaccination locations and availability. The dataset builds on Google Maps data to identify areas of the country where access to vaccines requires more than 15 minutes in travel time. This information is […]
Johns Hopkins Researchers Discuss Burden of Ultra-Expensive Drugs on Medicare as Spending Increases 1,170%
Researchers at the Johns Hopkins Bloomberg School of Public Health published an article on a select category of medications: ultra-expensive drugs. The number of these drugs covered by Medicare Part D increased from 23 to 122 between 2012 to 2018, leading to a shocking 1,170% spending surge on these […]
PRMA Consulting Webinar Discusses Strengthening GVDs
PRMA is offering an on-demand webinar on global value dossiers (GVDs). Suboptimal GVDs can lead to misused time and resources, including excessive costs. The webinar is hosted by Associate Director Claire Chadwick and Senior Analyst Jonathan Hailwood. They will discuss common exclusions in GVDs, […]
CEVR Researchers Publish Article on Strengths of Value-Based Healthcare and HTAs
Leading researchers at Tufts University School of Medicine’s Center for the Evaluation of Value and Risk in Health (CEVR) have published a commentary regarding value-based healthcare and using a health technology assessment (HTA) to regulate drug prices. Authors Peter Neumann, Daniel Ollendorf, and […]
PRMA Consulting Highlights Leading Women in Market Access IT Sector
Women constitute a small percentage of the information technology applicant pool; only 17% of information and communication technology specialists in Europe are women. However, PRMA Consulting notes that despite the small pool of applicants, it has been able to attract women to 100% of leadership […]
PRMA Consulting Offers Regenerative Medicine and Rare Disease Market Access Insight
PRMA Consulting is offering a selection of case studies that reflect the challenges facing stakeholders when considering market access strategies for rare disease drugs, orphan treatments, and regenerative medicine therapies. The free compilation includes important insight for pharma professionals, […]
FDA Turns Down Verily’s Application to Monitor Parkinson’s Disease Using Smartwatch
The Food and Drug Administration (FDA) has rejected Verily’s application to use a smartwatch to assess the severity of Parkinson’s disease remotely. The smartwatch reminds patients to complete a range of motor tasks weekly. The device is meant to track any changes in disease progression, but the FDA […]
Incoming NPC President and CEO Emphasizes Interdisciplinary Collaboration to Improve Healthcare
John O’Brien took on the positions of president and CEO of the National Pharmaceutical Council (NPC) on June 1st, 2021. His diverse background as a pharmacist, insurance executive, and federal health official will strengthen his new roles at NPC. He seeks to work with stakeholders from all sectors […]
Considerations for Biotech Investors Include a Robust Market Access Strategy and Value-Based Pricing
Market access expert Colin Wight details ten key considerations for investors in biotechnology and biopharma. He notes that implementing a well-rounded market access strategy should begin at the early stages of the research pipeline and that the final product’s price should be based on its […]
Survey Shows Americans Strongly Support Medicare Negotiation Amid Pharma’s Claims of Negative Impact to Innovation
A new survey shows that most Americans, both Democrats and Republicans, support negotiation by the federal government in prices of drugs receiving Medicare coverage. Although many claims have been made that such a shift in policy would negatively impact pharmaceutical innovation, less than 20% of […]
ICER Publishes Fairness Assessment Protocol in New Healthcare Equity Initiative
The Institute for Clinical and Economic Review (ICER) will begin considering barriers to drug access in an effort to promote both fair pricing and also fair access. ICER has published a whitepaper on the necessary components needed for fair access to drugs and more recently a protocol detailing how […]
Podcast on Limiting Medical Misinformation During COVID-19 Pandemic
Director and Global Head of Healthcare and Public Health Partnerships at YouTube/Google Dr. Garth Graham was invited to share his thoughts on reducing the spread of misinformation during the COVID-19 pandemic. He noted that consumers should take care to select trustworthy news sources and that both […]
[Podcast] A Health Podyssey Invites CMS Director to Share Insight on Biden’s Healthcare Plans
Alan Weil of Health Affairs’ A Health Podyssey series invited Liz Fowler, deputy administrator of the Centers for Medicare and Medicaid (CMS) and director of the Center for Medicare and Medicaid Innovation. She shares her thoughts on President Biden’s healthcare priorities and key healthcare trends, […]
AHIP Analysis Finds High Healthcare Spending on Prescription Drugs by Payers
America’s Health Insurance Plans (AHIP) has found that the largest proportion of payers’ healthcare spending goes to prescription drugs, upon analyzing data from 30 payers between 2016 to 2018. Closely behind this leading category are hospital costs and provider visits. The study reflects an updated […]
